Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

871 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of renal function on blood pressure control and outcome in thrombolyzed patients after acute ischemic stroke: post-hoc analysis of the ENCHANTED trial.
Ren X, Chen C, Wang X, Li Q, Zhao Y, You S, Ouyang M, Robinson T, Lindley RI, Arima H, Chen X, Chalmers J, Anderson CS, Song L. Ren X, et al. Among authors: ouyang m. Front Endocrinol (Lausanne). 2024 Dec 9;15:1341902. doi: 10.3389/fendo.2024.1341902. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39717107 Free PMC article. Clinical Trial.
Implementation of a goal-directed Care Bundle for intracerebral hemorrhage: Results of embedded process evaluation in the INTERACT3 trial.
Ouyang M, Anjum A, Mc Cawley FG, Wasay M, Ma L, Hu X, Chen X, Malavera A, Li X, Venturelli PM, Silva HA, Thang NH, Wahab KW, Pandian JD, Pontes-Neto OM, Abanto C, Cano-Nigenda V, Arauz A, You C, Jan S, Song L, Anderson CS, Liu H; INTERACT3 Investigators. Ouyang M, et al. PLOS Glob Public Health. 2024 Dec 19;4(12):e0003711. doi: 10.1371/journal.pgph.0003711. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39700102 Free PMC article.
Cost-effectiveness analysis of tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma: perspectives from the United States and China.
Lang W, Ai Q, Zhang W, Jiang Q, He Y, Ouyang M. Lang W, et al. Among authors: ouyang m. Front Pharmacol. 2024 Nov 20;15:1461571. doi: 10.3389/fphar.2024.1461571. eCollection 2024. Front Pharmacol. 2024. PMID: 39635432 Free PMC article.
871 results